BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Boston Biomedica, Inc. 

375 West Street

W. Bridgewater  Massachusetts  02379  U.S.A.
Phone: 508-580-1900 Fax: 508-580-1110


SEARCH JOBS


Boston Biomedica, Inc. provides products and services for the detection and monitoring of infectious diseases such as AIDS and Viral Hepatitis. BBI has three operating business units:

  • BBI Diagnostics, an ISO 9001 certified manufacturer and supplier of quality control and diagnostics reagents used to increase the accuracy of in vitro diagnostic tests.
  • BBI Biotech Research Laboratories, a research and development center providing R&D support for the other BBI business units, as well as contract research and repository services for the government, industry and other third parties.
  • BBI Source Scientific, an ISO 9001 certified manufacturer of diagnostic instrumentation and medical devices.


In addition, BBI is conducting research and development in Pressure Cycling Technology (PCT) through its subsidiary BBI BioSeq, with the goal of introducing new solutions for a number of important healthcare issues, including: inactivation of pathogens in human plasma, extraction of nucleic acids, food safety, and genomics. BBI also maintains a passive investment in Panacos Pharmaceuticals, a privately held antiviral drug and vaccine development company recently spun-off from BBI, whose goal is to introduce new solutions for the treatment of infectious diseases.

Last Updated 8-28-01


 Key Statistics


Email:
Ownership:

Web Site: Boston Biomedica, Inc.
Employees: 275
Symbol: BBII
 



Industry
Biotechnology






 Company News
Pressure BioSciences, Inc. (BBII) Announces Stock Repurchase Program 9/25/2006 9:57:15 AM
Pressure BioSciences, Inc. (BBII) Announces Extension Of Tender Offer10/19/2005 5:12:38 PM
Boston Biomedica (BBII) Announces Sale Of BBI Source Scientific10/19/2005 5:11:43 PM
Boston Biomedica (BBII) Reports First Quarter 2004 Financial Results10/19/2005 5:11:23 PM
Boston Biomedica (BBII) Announces The Appointment Of Richard T. Schumacher As Chief Executive Officer (CEO)10/19/2005 5:10:58 PM
Boston Biomedica (BBII) Announces Agreement To Sell its Diagnostics And Biotech Divisions To SeraCare Life Sciences, Inc. (SRLS) 10/19/2005 5:10:56 PM
Boston Biomedica (BBII) Reports Third Quarter Operating Results10/19/2005 5:10:47 PM
Boston Biomedica (BBII) Reports Fourth Quarter And Fiscal Year End 2003 Financial Results10/19/2005 5:10:40 PM
Michael N. Avallone Promoted To Chief Financial Officer Of Boston Biomedica (BBII)10/19/2005 5:10:31 PM
Boston Biomedica (BBII) Announces Completion Of A $2.5 Million Revolving Credit And Security Agreement10/19/2005 5:09:59 PM
12